Page 8 - Juncker Plan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

EIB Group signed 27 operations in Portugal in 2020 The measures taken by the EIB to mitigate the effects of the pandemic focused on two main areas: the healthcare sector and small and medium-sized enterprises (SMEs). EIB | Lisbon | Updated: 09-02-2021 22:33 IST | Created: 09-02-2021 22:33 IST Overall financing from the EIB Group in 2020 reached €76.8 billion (an increase of 6% compared to 2019), with €66.09 billion provided in the form of loans from the EIB and €12.87 billion released via the EIF, the subsidiary of the EIB. Image Credit: Flickr The European Investment Bank Group (EI...

Covid-19 in Bulgaria: Day 338 published on 2/8/21 7:25 PM Photo: BTA Health authorities in Bulgaria decide to accelerate vaccination against Covid-19 All delivered quantities of the AstraZeneca vaccine should be used for administering the first dose of the vaccination, Bulgaria's National Vaccine Task Force decided. This will cover larger groups of the population and will speed up immunization. The vaccine body will recommend that medical professionals administer the second dose of the vaccine 10 weeks after the first.  The members of the vaccination authorities expressed th...

Press release content from Business Wire. The AP news staff was not involved in its creation. iBiopsy®: Median Technologies Inks a Major Research Collaboration Agreement With the University of California San Diego (UC San Diego) February 9, 2021 GMT Regulatory News: Median Technologies (Paris:ALMDT) (ALMDT:PA) announces today the company has signed a research collaboration agreement with the University of California San Diego (UC San Diego) aimed at carrying out a study that will be used for its proprietary imaging platform iBiopsy® validation. The study is related to the iBiopsy® NASH Cli...

(1) The research collaboration agreement covers a joint clinical retrospective study on liver fibrosis severity in Non-Alcoholic Steato-Hepatitis (NASH) patients The collaboration will enable Median to work on a large NASH patient cohort to lead the validation of its iBiopsy's AI technology, applied to liver fibrosis characterization The Liver Center at UC San Diego is a world-renowned university and healthcare center for liver diseases, with a focus on Non-Alcoholic Fatty Liver Disease (NAFLD) NASH Regulatory News: Median Technologies (Paris:ALMDT) (ALMDT:PA) announces today the company has ...

The European Fund for Strategic Investments: The Legacy The European Fund for Strategic Investments as a game-changer for future economic stimulus programmes backed by EU public financing and for the European Investment Bank Publication information Where would you like to collect your ebook ? The inside story of the European Fund for Strategic Investments from 2015 to 2020 told through interviews with the Managing Director, Deputy Managing Director, members of the Investment Committee and final beneficiaries across Europe. The architects of this €500 billion-plus programme, the head of the...